Jane Street’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,831
Closed -$988K 13173
2025
Q4
$1.04M Sell
55,831
-135,966
-71% -$2.26M ﹤0.01% 6033
2025
Q3
$2.8M Buy
191,797
+149,033
+349% +$1.88M ﹤0.01% 4341
2025
Q2
$472K Sell
42,764
-98,120
-70% -$954K ﹤0.01% 7031
2025
Q1
$1.26M Buy
140,884
+88,540
+169% +$824K ﹤0.01% 5145
2024
Q4
$493K Sell
52,344
-92,231
-64% -$839K ﹤0.01% 6806
2024
Q3
$1.17M Buy
144,575
+1,640
+1% +$14.2K ﹤0.01% 5584
2024
Q2
$1.21M Buy
142,935
+109,327
+325% +$987K ﹤0.01% 5413
2024
Q1
$301K Sell
33,608
-337,909
-91% -$3.13M ﹤0.01% 7559
2023
Q4
$4.18M Sell
371,517
-87,994
-19% -$886K 0.01% 3122
2023
Q3
$3.97M Buy
459,511
+33,091
+8% +$319K 0.01% 2948
2023
Q2
$4.41M Buy
426,420
+303,654
+247% +$3.35M 0.01% 2929
2023
Q1
$1.33M Sell
122,766
-23,388
-16% -$247K ﹤0.01% 4494
2022
Q4
$1.64M Sell
146,154
-43,793
-23% -$460K ﹤0.01% 4168
2022
Q3
$1.93M Buy
189,947
+103,214
+119% +$967K ﹤0.01% 4260
2022
Q2
$786K Sell
86,733
-36,601
-30% -$337K ﹤0.01% 5925
2022
Q1
$1.18M Buy
123,334
+70,068
+132% +$687K ﹤0.01% 5786
2021
Q4
$589K Buy
53,266
+38,820
+269% +$338K ﹤0.01% 6953
2021
Q3
$107K Buy
+14,446
New +$162K ﹤0.01% 9261
2021
Q2
Sell
-14,192
Closed -$290K 10462
2021
Q1
$290K Buy
+14,192
New +$270K ﹤0.01% 7749
2020
Q4
Sell
-21,140
Closed -$313K 8173
2020
Q3
$313K Sell
21,140
-1,197,772
-98% -$22.4M ﹤0.01% 5821
2020
Q2
$25.6M Buy
+1,218,912
New +$31.3M 0.1% 631
2018
Q2
Sell
-141,329
Closed -$3.43M 5680
2018
Q1
$3.43M Buy
+141,329
New +$3.88M 0.03% 1283
2016
Q2
Sell
-10,584
Closed -$199K 4642
2016
Q1
$199K Buy
+10,584
New +$173K ﹤0.01% 3713

Other funds holding TBPH